洁特生物：11月21日召开董事会会议

Group 1 - The core point of the article is that Jiet Biotech (SH 688026) held its 25th meeting of the fourth board of directors on November 21, 2025, via telecommunication, where it reviewed the proposal regarding not adjusting the conversion price of "Jiet Convertible Bonds" [1] - For the year 2024, Jiet Biotech's revenue composition is as follows: consumables account for 95.02% of total revenue, while other businesses account for 4.98% [1] - As of the report date, Jiet Biotech has a market capitalization of 2.4 billion yuan [1]